These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I. Jameson E, Jones S, Wraith JE. Cochrane Database Syst Rev; 2013 Nov 21; (11):CD009354. PubMed ID: 24257962 [Abstract] [Full Text] [Related]
11. Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome. Thomas JA, Jacobs S, Kierstein J, Van Hove J. J Inherit Metab Dis; 2006 Dec 08; 29(6):762. PubMed ID: 17089217 [Abstract] [Full Text] [Related]
12. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Swiedler SJ, Kakkis ED, Braakman T, Chadbourne E, Walton-Bowen K, Cox GF. J Pediatr; 2004 May 08; 144(5):581-8. PubMed ID: 15126990 [Abstract] [Full Text] [Related]